Global Hospital Acquired Infection Control Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product;

Sterilants - Heat Sterilization Equipment, Low Temperature Sterilization Equipment, Radiation Sterilization Equipment and Other Sterilants, Disinfectants, and Other Products.

By Indications;

Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infections, and Other Indications.

By End Users;

Hospitals and Intensive Care Units, Ambulatory Surgical and Diagnostic Centers, Nursing Homes and Maternity Centers, and Other End Users.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn116518298 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Hospital Acquired Infection Control Market (USD Million), 2021 - 2031

In the year 2024, the Global Hospital Acquired Infection Control Market was valued at USD 23,937.23 million. The size of this market is expected to increase to USD 32,903.99 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.7%.

The global hospital acquired infection control market plays a critical role in safeguarding public health by mitigating the risks associated with infections acquired during hospital stays. Hospital-acquired infections (HAIs) pose significant challenges to patient safety and can lead to prolonged hospitalization, increased healthcare costs, and, in severe cases, mortality. As healthcare facilities strive to maintain sterile environments, the demand for advanced infection control solutions continues to escalate. These solutions encompass a wide range of products and technologies, including disinfectants, sterilization equipment, protective apparel, and surveillance systems, designed to prevent the transmission of pathogens within healthcare settings.

The prevalence of hospital-acquired infections underscores the importance of robust infection control measures across healthcare institutions worldwide. Factors such as the increasing incidence of antibiotic-resistant pathogens, rising awareness about infection prevention, and stringent regulatory standards are driving the growth of the global market. Additionally, the ongoing COVID-19 pandemic has spotlighted the critical need for effective infection control protocols, further accelerating market expansion. Healthcare providers are increasingly adopting innovative strategies and technologies to enhance infection prevention practices and minimize the risk of transmission within hospital environments.

Collaborations between healthcare organizations and research institutions are fostering the development of novel infection control solutions, including antimicrobial coatings, advanced disinfection techniques, and automated surveillance systems. These innovations aim to address evolving challenges in infection prevention and control, ensuring safer healthcare environments for patients, healthcare workers, and visitors. Furthermore, initiatives aimed at standardizing infection control protocols and promoting adherence to best practices are shaping the regulatory landscape and driving market growth. Overall, the global hospital acquired infection control market is poised for significant advancement as stakeholders prioritize patient safety and infection prevention as integral components of healthcare delivery.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Indications
    3. Market Snapshot, By End Users
    4. Market Snapshot, By Region
  4. Global Hospital Acquired Infection Control Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing awareness, regulations
        2. Technological advancements, innovation
        3. Rising prevalence, healthcare-associated infections
        4. Growing healthcare expenditure
        5. Emphasis on infection prevention
      2. Restraints
        1. High cost, limited budgets
        2. Resistance to antimicrobial agents
        3. Lack of skilled professionals
        4. Stringent regulatory requirements
        5. Economic downturns, uncertainties
      3. Opportunities
        1. Emerging markets, untapped potential
        2. Development of novel products
        3. Collaborations, partnerships
        4. Focus on patient safety
        5. Integration of AI, IoT
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Hospital Acquired Infection Control Market, By Product, 2021 - 2031(USD Million)
      1. Sterilants
        1. Heat Sterilization Equipment
        2. Low Temperature Sterilization Equipment
        3. Radiation Sterilization Equipment
        4. Other Sterilants
      2. Disinfectants
      3. Other Products
    2. Global Hospital Acquired Infection Control Market, By Indications, 2021 - 2031 (USD Million)
      1. Hospital Acquired Pneumonia
      2. Bloodstream Infections
      3. Surgical Site Infections
      4. Gastrointestinal Infections
      5. Urinary Tract Infections
      6. Other Indications
    3. Global Hospital Acquired Infection Control Market, By End Users, 2021 - 2031 (USD Million)
      1. Hospitals and Intensive Care Units
      2. Ambulatory Surgical and Diagnostic Centers
      3. Nursing Homes and Maternity Centers
      4. Other End Users
    4. Global Hospital Acquired Infection Control Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. 3M Company
      2. Becton, Dickinson and Company
      3. Belimed AG
      4. Biomerieux Sa
      5. Cantel Medical
      6. Ethicon
      7. Getinge Group
      8. Kimberly-Clark Corporation
      9. Sterigenics International LLC
      10. Steris Corporation
  7. Analyst Views
  8. Future Outlook of the Market